Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

506 public trials 166 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Recruiting

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

NCT06935357

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Applied Research Center of Arkansas Little Rock, Arkansas, United States
  • Kidney & Hypertension Center - Apple Valley Apple Valley, California, United States
  • Scripps Green Hospital Carlsbad, California, United States
  • National Institute of clinical Research Administration Office Garden Grove, California, United States
View all 258 locations
View Trial Details
Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis Health Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Health Gainesville, Florida, United States
View all 23 locations
View Trial Details
Recruiting

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

NCT07570862

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • Wallace Rheumatic Studies Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Miami Dermatology and Laser Research Miami, Florida, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Recruiting

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

NCT07268638

Conditions
Chronic Disease, Disease Attributes, Female Urogenital Diseases, +17 more
Locations
  • Investigator Site #2 Chula Vista, California, United States
  • Investigator Site #14 Los Angeles, California, United States
  • Investigator Site #12 San Dimas, California, United States
  • Investigator Site #13 Arvada, Colorado, United States
View all 25 locations
View Trial Details
Recruiting

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

NCT06975787

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Baylor College of Medicine Houston, Texas, United States
  • Centre Hospitalier Universitaire (CHU) Bordeaux Bordeaux, New Aquitaine, France
  • University Hospital Regensburg Regensburg, Bavaria, Germany
View all 18 locations
View Trial Details
Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

NCT06897930

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Stanford, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
View all 20 locations
View Trial Details

Related conditions